Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Isoflurane Sevoflurane Or Desflurane

Research Leaders

5 sponsors active, led by Melbourne Health

Related Conditions

Often studied with 15 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 2 (1)
Phase 4 (1)

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07072728Phase 2Recruiting

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

NCT04074460Phase 4Completed

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study

Showing all 2 trials

Research Network

Common Treatments

  • Isoflurane Sevoflurane Or Desflurane1
  • Propofol1
  • Psilocybin1

Active Sponsors

  • Melbourne Health1
  • Peter MacCallum Cancer Centre, Australia1
  • Psyence Australia Pty Ltd1
  • M.D. Anderson Cancer Center1
  • The Alfred1

Top Investigators

Related Conditions

  • Adjustment Disorder1
  • Cancer Of Stomach1
  • Cancer Other1
  • Cancer Of Endometrium1
  • Cancer Prostate1

Activity Timeline